User profiles for A. Haromy

Alois Haromy

University of Alberta
Verified email at ualberta.ca
Cited by 9956

Metabolic modulation of glioblastoma with dichloroacetate

…, P Dromparis, L Webster, A Haromy… - Science translational …, 2010 - science.org
Solid tumors, including the aggressive primary brain cancer glioblastoma multiforme,
develop resistance to cell death, in part as a result of a switch from mitochondrial oxidative …

An abnormal mitochondrial–hypoxia inducible factor-1α–Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded …

…, B Thébaud, S Bonnet, A Haromy… - Circulation, 2006 - Am Heart Assoc
Background— The cause of pulmonary arterial hypertension (PAH) was investigated in humans
and fawn hooded rats (FHR), a spontaneously pulmonary hypertensive strain. Methods …

Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury …

…, F Eaton, K Hashimoto, G Harry, A Haromy… - Circulation, 2005 - Am Heart Assoc
Background— Bronchopulmonary dysplasia (BPD) and pulmonary emphysema, both
significant global health problems, are characterized by a loss of alveoli. Vascular endothelial …

Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis

…, S Bonnet, X Wu, JRB Dyck, A Haromy… - Circulation …, 2004 - Am Heart Assoc
The pulmonary arteries (PA) in pulmonary arterial hypertension (PAH) are constricted and
remodeled;. They have suppressed apoptosis, partly attributable to suppression of the bone …

Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility

…, SL Archer, D Soliman, V Gurtu, R Moudgil, A Haromy… - Circulation, 2007 - Am Heart Assoc
Background— Sildenafil was recently approved for the treatment of pulmonary arterial
hypertension. The beneficial effects of phosphodiesterase type 5 (PDE5) inhibitors in pulmonary …

Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats

…, GJ Rey-Parra, J Galipeau, A Haromy… - American journal of …, 2009 - atsjournals.org
Rationale: Bronchopulmonary dysplasia (BPD) and emphysema are characterized by arrested
alveolar development or loss of alveoli; both are significant global health problems and …

[HTML][HTML] Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension

…, DC Altieri, S Bonnet, A Haromy… - The Journal of …, 2005 - Am Soc Clin Investig
Pulmonary arterial hypertension (PAH) is characterized by genetic and acquired abnormalities
that suppress apoptosis and enhance cell proliferation in the vascular wall, including …

The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted

…, G Sutendra, SL Archer, A Haromy… - Proceedings of the …, 2007 - National Acad Sciences
In pulmonary arterial hypertension (PAH), antiapoptotic, proliferative, and inflammatory
diatheses converge to create an obstructive vasculopathy. A selective down-regulation of the Kv …

Diversity in mitochondrial function explains differences in vascular oxygen sensing

…, V Hampl, A Nsair, XC Wu, G Harry, A Haromy… - Circulation …, 2002 - Am Heart Assoc
Renal arteries (RAs) dilate in response to hypoxia, whereas the pulmonary arteries (PAs)
constrict. In the PA, O 2 tension is detected by an unidentified redox sensor, which controls K + …

[HTML][HTML] A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth

S Bonnet, SL Archer, J Allalunis-Turner, A Haromy… - Cancer cell, 2007 - cell.com
The unique metabolic profile of cancer (aerobic glycolysis) might confer apoptosis resistance
and be therapeutically targeted. Compared to normal cells, several human cancers have …